Calais J, Gafita A, Eiber MR, Armstrong WR, et al. Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with (177)Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort. J Nucl Med 2021 May 20. pii: jnumed.121.261982. doi: 10.2967/jnumed.121.261982.
PMID: 34016732